Inspire Medical Systems, Inc. INSP
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -1.96% | -23.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.96% | -23.97% | |||
| Cost of Revenue | 5.24% | -23.29% | |||
| Gross Profit | -3.08% | -24.07% | |||
| SG&A Expenses | -3.24% | -6.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.24% | -7.74% | |||
| Operating Income | 54.03% | -102.42% | |||
| Income Before Tax | 29.95% | -95.24% | |||
| Income Tax Expenses | -79.54% | 115.96% | |||
| Earnings from Continuing Operations | 102.78% | -108.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 102.78% | -108.30% | |||
| EBIT | 54.03% | -102.42% | |||
| EBITDA | 2.28% | -92.01% | |||
| EPS Basic | 102.77% | -108.37% | |||
| Normalized Basic EPS | 29.31% | -94.78% | |||
| EPS Diluted | 102.54% | -108.44% | |||
| Normalized Diluted EPS | 28.93% | -94.73% | |||
| Average Basic Shares Outstanding | 0.47% | -0.84% | |||
| Average Diluted Shares Outstanding | 0.84% | -1.77% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||